Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in J Gastroenterol

Retrieve available abstracts of 24 articles:
HTML format

Single Articles

    November 2022
  1. IWASHITA T, Iwata K, Hamada T, Saito T, et al
    Supportive treatment during the periprocedural period of endoscopic treatment for pancreatic fluid collections: a critical review of current knowledge and future perspectives.
    J Gastroenterol. 2022 Nov 7. pii: 10.1007/s00535-022-01935.
    PubMed     Abstract available

    October 2022
  2. HISADA Y, Hijioka S, Ikeda G, Maehara K, et al
    Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide NCC Oncopanel System analysis suitability criteria: a single-arm, phase II clinical trial.
    J Gastroenterol. 2022 Oct 3. pii: 10.1007/s00535-022-01926.
    PubMed     Abstract available

    September 2022
  3. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
    The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    J Gastroenterol. 2022 Sep 26. pii: 10.1007/s00535-022-01920.
    PubMed     Abstract available

  4. KAWAKUBO K, Fernandez-Del Castillo C, Liss AS
    Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy.
    J Gastroenterol. 2022 Sep 17. pii: 10.1007/s00535-022-01922.

  5. KAWAKUBO K, Castillo CF, Liss AS
    Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy.
    J Gastroenterol. 2022 Sep 1. pii: 10.1007/s00535-022-01915.
    PubMed     Abstract available

    August 2022
  6. SHIMIZU K, Ito T, Irisawa A, Ohtsuka T, et al
    Evidence-based clinical practice guidelines for chronic pancreatitis 2021.
    J Gastroenterol. 2022 Aug 22. pii: 10.1007/s00535-022-01911.
    PubMed     Abstract available

  7. UCHIDA K, Okazaki K
    Current status of type 1 (IgG4-related) autoimmune pancreatitis.
    J Gastroenterol. 2022 Aug 2. pii: 10.1007/s00535-022-01891.
    PubMed     Abstract available

    July 2022
  8. KANDA T, Wakiya T, Ishido K, Kimura N, et al
    Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas.
    J Gastroenterol. 2022 Jul 3. pii: 10.1007/s00535-022-01898.
    PubMed     Abstract available

    June 2022
  9. YAMAMOTO K, Iwadate D, Kato H, Nakai Y, et al
    Targeting autophagy as a therapeutic strategy against pancreatic cancer.
    J Gastroenterol. 2022 Jun 21. pii: 10.1007/s00535-022-01889.
    PubMed     Abstract available

  10. OKADA Y, Nakasone H, Nakamura Y, Kawamura M, et al
    Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation.
    J Gastroenterol. 2022 Jun 3. pii: 10.1007/s00535-022-01881.
    PubMed     Abstract available

    April 2022
  11. GAO L, Zhang H, Li G, Ye B, et al
    The clinical outcome from early versus delayed minimally invasive intervention for infected pancreatic necrosis: a systematic review and meta-analysis.
    J Gastroenterol. 2022 Apr 29. pii: 10.1007/s00535-022-01876.
    PubMed     Abstract available

    February 2022
  12. OKAZAKI K, Kawa S, Kamisawa T, Ikeura T, et al
    Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020.
    J Gastroenterol. 2022 Feb 22. pii: 10.1007/s00535-022-01857.
    PubMed     Abstract available

    January 2022
  13. KAWABATA H, Ono Y, Tamamura N, Oyama K, et al
    Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway.
    J Gastroenterol. 2022 Jan 11. pii: 10.1007/s00535-021-01846.
    PubMed     Abstract available

    August 2021
  14. CAO Z, Qiu J, Guo J, Xiong G, et al
    A randomised, multicentre trial of somatostatin to prevent clinically relevant postoperative pancreatic fistula in intermediate-risk patients after pancreaticoduodenectomy.
    J Gastroenterol. 2021 Aug 28. pii: 10.1007/s00535-021-01818.
    PubMed     Abstract available

  15. MASAKI Y, Nakase H, Tsuji Y, Nojima M, et al
    The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis.
    J Gastroenterol. 2021 Aug 24. pii: 10.1007/s00535-021-01817.
    PubMed     Abstract available

    July 2021
  16. CANNON A, Thompson CM, Bhatia R, Armstrong KA, et al
    Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.
    J Gastroenterol. 2021 Jul 19. pii: 10.1007/s00535-021-01800.
    PubMed     Abstract available

    A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer.
    J Gastroenterol. 2021 Jul 13. pii: 10.1007/s00535-021-01806.
    PubMed     Abstract available

    June 2021
  18. KURIYAMA K, Kodama Y, Shiokawa M, Nishikawa Y, et al
    Essential role of Notch/Hes1 signaling in postnatal pancreatic exocrine development.
    J Gastroenterol. 2021 Jun 14. pii: 10.1007/s00535-021-01779.
    PubMed     Abstract available

    March 2021
  19. WANG WQ, Zhang WH, Gao HL, Huang D, et al
    A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors.
    J Gastroenterol. 2021 Mar 19. pii: 10.1007/s00535-021-01777.
    PubMed     Abstract available

    February 2021
  20. LAI SW
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 5. pii: 10.1007/s00535-021-01764.

  21. BRUSSELAERS N, Sadr-Azodi O, Engstrand L
    Proton pump inhibitors and the risk of pancreatic cancer.
    J Gastroenterol. 2021 Feb 2. pii: 10.1007/s00535-021-01761.

    October 2020
  22. SAKAI A, Masuda A, Eguchi T, Anami T, et al
    Clinical outcome of conservatively managed pancreatic intraductal papillary mucinous neoplasms with mural nodules and main duct dilation.
    J Gastroenterol. 2020 Oct 28. pii: 10.1007/s00535-020-01739.
    PubMed     Abstract available

  23. TEZUKA K, Okamura Y, Sugiura T, Ito T, et al
    The influence of familial pancreatic cancer on postoperative outcome in pancreatic cancer: relevance to adjuvant chemotherapy.
    J Gastroenterol. 2020 Oct 22. pii: 10.1007/s00535-020-01730.
    PubMed     Abstract available

    August 2019
  24. HAKUTA R, Hamada T, Nakai Y, Oyama H, et al
    Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes.
    J Gastroenterol. 2019 Aug 31. pii: 10.1007/s00535-019-01612.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.